Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 491 Records) |
Query Trace: Carcinoma and PIK3CA[original query] |
---|
Investigating genomic, proteomic, and post-transcriptional regulation profiles in colorectal cancer: a comparative study between primary tumors and associated metastases. Cancer cell international 2023 9 23 (1): 192. Hersh Ham-Karim, Ola Negm, Narmeen Ahmad, Mohammad Ily |
PIK3CA mutations in cutaneous squamous cell carcinoma. Intractable & rare diseases research 2023 9 12 (3): 206-207. Yudo Kusaba, Ikko Kajihara, Ryoko Sakamoto, Saki Maeda-Otsuka, Saori Yamada-Kanazawa, Soichiro Sawamura, Katsunari Makino, Jun Aoi, Shinichi Masuguchi, Satoshi Fukushi |
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma. JCO precision oncology 2023 9 7 e2300272. Darren Cowzer, Jessica B White, Joanne F Chou, Pin-Jung Chen, Tae-Hyung Kim, Danny N Khalil, Imane H El Dika, Katrina Columna, Amin Yaqubie, Joseph S Light, Jinru Shia, Hooman Yarmohammadi, Joseph Patrick Erinjeri, Alice C Wei, William Jarnagin, Richard K G Do, David B Solit, Marinela Capanu, Ronak H Shah, Michael F Berger, Ghassan K Abou-Alfa, James J Hardi |
Prognostic significance of TP53 and PIK3CA mutations analyzed by next-generation sequencing in breast cancer. Medicine 2023 9 102 (38): e35267. Jin Hyuk Choi, Jesang Yu, Minjung Jung, Junyong Jekal, Ku Sang Kim, Sung Ui Ju |
Mutation Profile via Next-Generation Sequencing in Patients with Colorectal Adenocarcinoma and Its Clinicopathological Correlation. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2023 9 . Sibel Osman, Nesibe Kahraman Çetin, ?brahim Halil Erdo?du, ?brahim Meteo? |
Ovarian squamous cell carcinoma associated with teratoma: a report of six cases with genomic analysis. Pathology 2023 9 . Yun Liang, Huajuan Ruan, Minghua Yu, Bingjian |
CHB patients with rtA181T-mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes. Journal of viral hepatitis 2023 9 . Qiqi Ning, Tongwang Yang, Xianghua Guo, Yanxiang Huang, Yuxue Gao, Mengcheng Liu, Pengxiang Yang, Yuanyue Guan, Ning Liu, Yang Wang, Dexi Ch |
Real-world challenges in undertaking NTRK fusion testing in non-small cell lung cancer. Journal of thoracic disease 2023 8 15 (7): 3811-3817. Ashleigh Poh, Abdelaziz Sammour, Jared Mathai, Joanne Peverall, Chris Van Vliet, Khashayar Asadi, Sagun Para |
Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer. Experimental & molecular medicine 2023 7 . Ji-Yeon Kim, Sabin Park, Eun Yoon Cho, Jeong Eon Lee, Hae Hyun Jung, Byung Joo Chae, Seok Won Kim, Seok Jin Nam, Soo Youn Cho, Yeon Hee Park, Jin Seok Ahn, Semin Lee, Young-Hyuck |
Case Report: SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder with genetic analysis. Frontiers in oncology 2023 7 13 1086266. Xiangpeng Meng, Jia Ma, Nan Meng, Tianyu Yun, Beifang N |
Targeted treatment in a case series of AR+, HRAS/PIK3CA co-mutated salivary duct carcinoma. Frontiers in oncology 2023 7 13 1107134. Damian T Rieke, Sebastian Schröder, Philippe Schafhausen, Eric Blanc, Erika Zuljan, Benjamin von der Emde, Dieter Beule, Ulrich Keller, Ulrich Keilholz, Konrad Klinghamm |
Large, Nested Variant of Urothelial Carcinoma Is Enriched with Activating Mutations in Fibroblast Growth Factor Receptor-3 among Other Targetable Mutations. Cancers 2023 6 15 (12): . Yaser Gamallat, Mitra Afsharpad, Soufiane El Hallani, Christopher A Maher, Nimira Alimohamed, Eric Hyndman, Tarek A Bism |
The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer. Gynecologic oncology 2023 6 175 133-141. Jin Li, Xiaohong Xue, Yan Zhang, Fengna Ding, Wenyan Wu, Cuicui Liu, Yang Xu, Hanlin Chen, Qiuxiang Ou, Yang Shao, Xinjun Li, Fei Wu, Xiaohua |
Different Mutational Landscape in HPV-induced and HPV-independent Invasive Penile Squamous Cell Cancers. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 6 100250. Mikhail S Ermakov, Karl Kashofer, Sigrid Regau |
Association between PIK3CA activating mutations and outcomes in early-stage invasive lobular breast carcinoma treated with adjuvant systemic therapy. Radiology and oncology 2023 6 57 (2): 220-228. Domen Ribnikar, Valentina Jeric Horvat, Ivica Ratosa, Zachary W Veitch, Biljana Grcar Kuzmanov, Srdjan Novakovic, Erik Langerholc, Eitan Amir, Bostjan Seru |
Data mining on identifying diagnosis and prognosis biomarkers in head and neck squamous carcinoma. Scientific reports 2023 6 13 (1): 10020. Guoyuan Ju, Zhangyu Yao, Yanbin Zhao, Xiaotong Zhao, Fangzhou L |
Comprehensive genomic and immunohistochemical profiles and outcomes of immunotherapy in patients with recurrent or advanced cervical cancer. Frontiers in oncology 2023 5 13 1156973. Yoo-Na Kim, Kyunglim Lee, Eunhyang Park, Junsik Park, Yong Jae Lee, Eun Ji Nam, Sang Wun Kim, Sunghoon Kim, Young Tae Kim, Jung-Yun L |
Genetic landscape and PD-L1 expression in Epstein-Barr virus-associated gastric cancer according to the histological pattern. Scientific reports 2023 11 13 (1): 19487. Ji Hyun Park, Hee Jin Cho, Jeonghwa Seo, Ki Bum Park, Yong Hwan Kwon, Han Ik Bae, An Na Seo, Moonsik K |
Non-Lobular Invasive Breast Carcinomas with Bi-Allelic Pathogenic CDH1 Somatic Alterations: a Histologic, Immunophenotypic and Genomic Characterization. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 11 100375. Fatemeh Derakhshan, Arnaud Da Cruz Paula, Pier Selenica, Edaise M da Silva, Anne Grabenstetter, Sahar Jalali, Andrea M Gazzo, Higinio Dopeso, Antonio Marra, David N Brown, Dara S Ross, Diana Mandelker, Pedram Razavi, Sarat Chandarlapaty, Hannah Y Wen, Edi Brogi, Hong Zhang, Britta Weigelt, Fresia Pareja, Jorge S Reis-Fil |
Recurrent Somatic Copy Number Alterations and Their Association with Oncogene Expression Levels in High-Grade Ovarian Serous Carcinoma. Life (Basel, Switzerland) 2023 11 13 (11): . Hillary P Esplen, Richard K Yang, Awdhesh Kalia, Zhenya Tang, Guilin Tang, L Jeffrey Medeiros, Gokce A Torun |
A comparison between mutational profiles in tumour tissue DNA and circulating tumour DNA in head and neck squamous cell carcinoma---A systematic review. Mutation research. Reviews in mutation research 2023 11 108477. Xiaomin Huang, Paul Leo, Lee Jones, Pascal Hg Duijf, Gunter Hartel, Lizbeth Kenny, Sarju Vasani, Chamindie Punyadee |
The quest for the optimal biomarker: is extending the spectrum of targeted PIK3CA mutations in breast cancer carcinoma worthwhile? Annals of translational medicine 2023 11 11 (11): 393. Stanislas Quesada, William Jac |
Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection. International journal of cancer 2023 11 . Abderaouf Hamza, Julien Masliah-Planchon, Cindy Neuzillet, Jérémie H Lefèvre, Magali Svrcek, Sophie Vacher, Christine Bourneix, Matthieu Delaye, Diane Goéré, Peggy Dartigues, Emmanuelle Samalin, Marc Hilmi, Julien Lazartigues, Elodie Girard, Jean-François Emile, Eugénie Rigault, Virginie Dangles-Marie, Nathalie Rioux-Leclercq, Christelle de la Fouchardière, David Tougeron, Andrea Casadei-Gardini, Pascale Mariani, Frédérique Peschaud, Wulfran Cacheux, Astrid Lièvre, Ivan Bièc |
NOTCH1 and PIK3CA mutation are related to HPV-associated vulvar squamous cell carcinoma. Pathology, research and practice 2023 10 251 154877. M Choschzick, C Stergiou, A Gut, M Zoche, J S Ross, H Mo |
Prevalence and Associations of Co-occurrence of NFE2L2 Mutations and Chromosome 3q26 Amplification in Lung Cancer. Global medical genetics 2024 4 11 (2): 150-158. Jinfeng Liu, Sijie Liu, Dan Li, Hongbin Li, Fan Zha |
Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example. Molecular biomedicine 2024 4 5 (1): 13. Shutao Zheng, Shuo He, Yan Liang, Yiyi Tan, Qing Liu, Tao Liu, Xiaomei |
TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary Thyroid Carcinoma in a Colombian Cohort. Advances in therapy 2024 1 . Sergio D Cruz-Romero, Sebastián González, José Y Juez, David S Becerra, Ana M Baldión, José A Hakim, Deyanira González-Devia, Sandra Perdomo, Paula A Rodríguez-Urre |
Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis. Pathology, research and practice 2024 1 254 155142. Matteo Rosellini, Veronica Mollica, Andrea Marchetti, Sara Coluccelli, Francesca Giunchi, Elisa Tassinari, Costantino Ricci, Michelangelo Fiorentino, Giovanni Tallini, Dario De Biase, Francesco Massa |
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146. Journal for immunotherapy of cancer 2024 1 12 (1): . Vicky Makker, Matthew H Taylor, Carol Aghajanian, Allen L Cohn, Marcia S Brose, Christopher Di Simone, Zhu Alexander Cao, Leah Suttner, Andrey Loboda, Razvan Cristescu, Petar Jelinic, Robert Orlowski, Lea Dutta, Junji Matsui, Corina E Dutcus, Yukinori Minoshima, Mark J Messi |
Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatments. BMC cancer 2024 1 24 (1): 85. Mirai Ido, Kimihito Fujii, Hideyuki Mishima, Akihito Kubo, Masayuki Saito, Hirona Banno, Yukie Ito, Manami Goto, Takahito Ando, Yukako Mouri, Junko Kousaka, Tsuneo Imai, Shogo Naka |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: